Centro de Alergia y Enfermedades Respiratorias - Buenos Aires

Centro de Alergia y Enfermedades Respiratorias - Buenos Aires
Luis María Drago 250, CABA, Buenos Aires
Select an option

Our team

Medical staff
Alberto Jorge Tolcachier
Tania Zarowsky
Hugo Daniel Tedesco
Hernán Piza
Melina Verena Heinze

Open studies

Chronic bronchitis
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) - PILASTER - Chiesi Farmaceutici S.p.A.See more
Chronic obstructive pulmonary disease
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) - PILASTER - Chiesi Farmaceutici S.p.A.See more
Diabetes
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) - Eli Lilly and CompanySee more
Urticaria
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines - Novartis PharmaceuticalsSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy